Pulse Explorar nav.journalClub Debates Tendências Pesquisadores Revistas

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Início Explorar nav.journalClub Tendências

⌘+K

AI Drug Safety in Pregnancy | Synapse

April 25, 2026JAMA0 citations

View Full Paper

AI Drug Safety in Pregnancy

YHYulin HswenJambi University

Key Points

The aim is to explore how AI can improve drug safety assessments during pregnancy.
Interview with Yulin Hswen, AI Associate Editor at JAMA+.
Insights from Viktor H. Ahlqvist, a postdoctoral fellow in epidemiology.
AI technologies have potential applications in monitoring drug safety for pregnant individuals.
Discussions highlight the importance of integrating AI in maternal health assessments.

Abstract

JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, spoke with Viktor H. Ahlqvist, PhD, a postdoctoral fellow in the Unit of Integrative Epidemiology of the Institute of Environmental Medicine at Karolinska Institutet, for JAMA+ AI Conversations.

Perguntar à IA

Like

Bookmark

Share

View Full Paper

Cite This Study

Yulin Hswen (Thu,) studied this question.

synapsesocial.com/papers/69ec5a8888ba6daa22dac03f https://doi.org/https://doi.org/10.1001/jama.2025.24562

Perguntar à IA

Like

Bookmark

Share

View Full Paper